Site-specific antigen-adjuvant conjugation using cell-free protein synthesis enhances antigen presentation and CD8+ T-cell response
Abstract Antigen-adjuvant conjugation is known to enhance antigen-specific T-cell production in vaccine models, but scalable methods are required to generate site-specific conjugation for clinical translation of this technique. We report the use of the cell-free protein synthesis (CFPS) platform as...
Guardado en:
Autores principales: | Adam M. Weiss, Jainu Ajit, Tyler J. Albin, Neeraj Kapoor, Shilpa Maroju, Aym Berges, Lucy Pill, Jeff Fairman, Aaron P. Esser-Kahn |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6dea9876b850448097ee9e13c5ae1009 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development of combination adjuvant for efficient T cell and antibody response induction against protein antigen.
por: Yasunari Haseda, et al.
Publicado: (2021) -
Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants
por: Sonia Budroni, et al.
Publicado: (2021) -
Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice.
por: Annalisa Ciabattini, et al.
Publicado: (2011) -
Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression
por: Chungyong Han, et al.
Publicado: (2018) -
Antigen-Conjugated Silica Solid Sphere as Nanovaccine for Cancer Immunotherapy
por: Dong Y, et al.
Publicado: (2020)